Atypical Lipomatous Tumors: Should They be Treated Like Other Sarcoma or Not? Surgical Consideration from a Bi-Institutional Experience

Annals of Surgical Oncology

Volumn 21, Issue 13, 2014, Pages 4090-4097

  Mussi, Chiara Erminia ^a   Daolio, Primo ^b   Cimino, Matteo ^a   Giardina, Fabio ^b   De Sanctis, Rita ^a   Morenghi, Emanuela ^a   Parafioriti, Antonina ^b   Bartoli, Maria S ^b   Bastoni, Stefano ^b   Cozzaglio, Luca ^a   Colombo, Piergiuseppe ^a   Quagliuolo, Vittorio ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b Orthopaedic Institute Pini   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATYPICAL LIPOMATOUS TUMOR; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LIPOSARCOMA; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTINUCLEAR CELL; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PRIMARY TUMOR; REOPERATION; RETROSPECTIVE STUDY; STROMA CELL; AGED; CLINICAL TRIAL; COMPARATIVE STUDY; ITALY; LIPOMA; MIDDLE AGED; MULTICENTER STUDY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; PATHOLOGY; PROCEDURES; TREATMENT OUTCOME;

AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; ITALY; LIPOMA; LIPOSARCOMA; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; RETROSPECTIVE STUDIES; SURGICAL PROCEDURES, OPERATIVE; TREATMENT OUTCOME;

EID: 84911971156     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-014-3855-7     Document Type: Article

References (25)

1. Kooby DA, Antonescu CR, Brennan MF, et al. Atypical lipomatous tumor/well-differentiated liposarcoma of the extremity and trunk wall: importance of histological subtype with treatment recommendations. Ann Surg Oncol. 2004;11:78-84.
2. Coindre JM, Pédeutour F, Aurias A, et al. Well-differentiated and dedifferentiated liposarcomas. Virch Arch. 2010;456:167-79.
3. Rubin BP, Fletcher CDM. The cytogenetics of lipomatous tumours. Histopathology. 1997;30:507-511.
4. Mystakidou K, Panagiotou I, Brountzos E, Kouloulias V, et al. Well-differentiated hand liposarcoma with bone metastases treated successfully with zoledronic acid. Onkologie. 2011;34:706-709.
5. Gronchi A, Lo Vullo S, Colombo C, et al. Extremity soft tissue sarcoma in a series of patients treated at a single institution: local control directly impacts survival. Ann Surg. 2010;251:512–517.
6. Enneking WF. A system of staging musculoskeletal neoplasms. Clin Orthop. 1980;153:106–120.
7. Enneking WF, Spanier S, Goodman M, et al. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop. 1986;204:9-24, ASP 2004;11:476-82.
8. Gerrand CH, Wunder JS, Kandel RA, et al. The influence of anatomic location on functional outcome in lower-extremity soft tissue sarcoma. Ann Surg Oncol. 2004;11(5):476–482.
9. Dalal KM, Kattan MW, Antonescu CR, et al. Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg. 2006;244:381–191.
10. Cahlon O, Brennan MF, Jia X, et al. A postoperative nomogram for local recurrence risk in extremity soft tissue sarcomas after limb-sparing surgery without adjuvant radiation. Ann Surg. 2012;255:343–347.
11. Eilber FC, Brennan MF, Riedel E, et al. Prognostic factors for survival in patients with locally recurrent extremity soft tissue sarcomas. Ann Surg Oncol. 2008;12:228–236.
12. Fiore M, Casali PG, Miceli R, et al. Prognostic effect of re-excision in adult soft tissue sarcoma of the extremity. Ann Surg Oncol. 2006;13:110–117.
13. Weaver J, Rao P, Goldblum JR, et al. Can MDM2 analytical tests performed on core needle biopsy be relied upon to diagnose well-differentiated liposarcoma? Mod Pathol. 2010;23:1301–1306.
14. Arrigoni G, Doglioni G. Atypical lipomatous tumor: molecular characterization. Curr Opin Oncol. 2004; 16:355–358.
15. Trotti A, Colevas AD, Setser A, et al. CTCAE v3.0: development of a comprehensive grading system for the adverse events of cancer treatment. Semin Radiat Oncol. 2003; 13:176–181.
16. National Cancer Institute, National Institutes of Health, US Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE) version 4.0. Published 28 May 2009; revised version 4.03 June 14, 2010. Available from: http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14QuickReference_5x7.pdf2010-06-14QuickReference_5x7.pdf. Accessed 20 May 2013.
17. Fletcher CDM, Bridge JA, Hogendoorn P et al. WHO classification of tumours of soft tissue and bone: IARC, Lyon, 2013.
18. Coindre JM, Trojani M, Contesso G, et al. Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer. 1986;58:306–309.
19. Mussi C, Collini P, Miceli R, et al. The prognostic impact of dedifferentiation in retroperitoneal liposarcoma: a series of surgically treated patients at a single institution. Cancer. 2008;113:1657–1665.
20. Mavrogenis AF, Lesensky J, Romagnoli C, et al. Atypical lipomatous tumor/well-differentiated liposarcomas: clinical outcome of 67 patients. Orthopedics. 2011;34:893–898.
21. Gutierrez JC, Perez EA, Moffat FL, et al. Should soft tissue sarcomas be treated at high-volume centers? An analysis of 4205 patients. Ann Surg. 2007;245:952–958.
22. Smith CA, Martinez SR, Tseng WH, et al. Predicting survival for well-differentiated liposarcoma: the importance of tumor location. J Surg Res. 2012;175:12–17.
23. Kubo T, Sugita T, Shimose S, Arihiro K, et al. Conservative surgery for well-differentiated liposarcomas of the extremities adjacent to major neurovascular structures. Surg Oncol. 2006;15:167–171.
24. Kimura H, Dobashi Y, Nojima T, et al. Utility of fluorescence in situ hybridization to detect MDM2 amplification in liposarcomas and their morphological mimics. Int J Clin Exp Pathol. 2013;6:1306–1316.
25. Einarsdóttir H, Skoog L, Söderlund V, et al. Accuracy of cytology for diagnosis of lipomatous tumors: comparison with magnetic resonance and computed tomography findings in 175 cases. Acta Radiol. 2004;45:840–846.